Reye's syndrome associated with long-term aspirin therapy
Related Experiment Video
Updated: Oct 23, 2026

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Insights
Reye's syndrome is rarely seen in children on long-term salicylate treatment. This study highlights two cases, emphasizing the need for liver function monitoring in these pediatric patients.
Area of Science:
- Pediatrics
- Pharmacology
- Toxicology
Background:
- Salicylate therapy is common for various pediatric conditions.
- Reye's syndrome is a rare but serious condition associated with salicylate use.
- Long-term salicylate use in children requires careful consideration of potential adverse effects.
Observation:
- Two pediatric cases of Reye's syndrome are presented.
- Both children were receiving long-term salicylate therapy for systemic inflammatory disorders.
- The development of Reye's syndrome occurred during ongoing salicylate treatment.
Findings:
- Reye's syndrome developed in children despite adherence to prescribed salicylate therapy.
- Clinical and laboratory findings consistent with Reye's syndrome were observed.
- Hepatocellular dysfunction was a key indicator in the reported cases.
Implications:
- Healthcare providers should consider Reye's syndrome in children on long-term salicylates presenting with relevant symptoms.
- Regular monitoring of liver function is crucial for pediatric patients on extended salicylate treatment.
- This underscores the importance of risk-benefit assessment in chronic salicylate therapy for children.
Abstract:
Reye's syndrome has been infrequently described in children receiving long-term salicylate therapy. We report the clinical and laboratory findings of two children in whom Reye's syndrome developed while taking salicylates for systemic inflammatory disorders. Monitoring of hepatocellular function should be considered in children who are receiving long-term salicylate therapy.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Drug Toxicity: Risk factors
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Diabetic Retinopathy
Gastroesophageal Reflux Disease

